Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Purple Biotech Ltd. Sponsored ADR (PPBT) had Operating Cash Flow per Share of $-1.29 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.08M |
|
-- |
|
-- |
|
$1.24M |
|
$-1.24M |
|
$0.15M |
|
$-1.09M |
|
$-1.09M |
|
$-1.09M |
|
$-1.09M |
|
$-1.09M |
|
$-1.09M |
|
$-1.24M |
|
$-1.19M |
|
2.74M |
|
2.74M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$6.31M |
|
$0.14M |
|
$28.07M |
|
$34.38M |
|
$2.19M |
|
-- |
|
$0.14M |
|
$2.33M |
|
$32.05M |
|
$4.21M |
|
$32.05M |
|
-- |
|
| Cash Flow Statement Financials | |
$-3.52M |
|
$0.36M |
|
$0.47M |
|
$7.40M |
|
$4.74M |
|
$-2.67M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3.40% |
|
-25.89% |
|
-3.17% |
|
-3.40% |
|
-- |
|
$-1.29 |
|
|
Operating Cash Flow per Share |
$-1.29 |